NEW YORK (GenomeWeb News) – Agilent Technologies said today that Swiss genomics services company Fasteris will provide Agilent's target enrichment services for next-generation sequencing.

Fasteris was named the first European Certified-Service Provider for Agilent's SureSelect Target Enrichment System, Agilent said.

Fasteris demonstrated proficiency using the SureSelect system with Illumina's Genome Analyzer. Agilent and Illumina have a non-exclusive co-marketing agreement that supports the Agilent system as optimized for the Genome Analyzer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.

Apr
27
Sponsored by
SeraCare

This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.